Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
Clinical trial NCT05008965 · RECRUITING
Trial details
- NCT number
- NCT05008965
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2027-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.